What is the main business of PPB 21?

The main business activity of PPB 21 focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on April 12, 2021.

Where is the headquarters located?

The headquarters is located at: ul. Onufrego Zagłoby 16, 54-514 Wrocław.

Who is on the management board?

The management board consists of: Jan Święszkowski (President of the Management Board) and Karol Wacław Teliga (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

PPB 21sp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2021-04-12

Share capital

5,000.00 PLN

Registered address

ul. Onufrego Zagłoby 16, 54-514 Wrocław, Poland

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 4 financial statements were filed late (the longest delay 997 days for 2021).

2025not filed
202407/04/2025
202307/04/2025
202207/04/2025
202107/04/2025

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

Research and experimental development on biotechnology (72.11.Z)Primary

Authorized Representatives

Jan Święszkowski – President of the Management Board

Karol Wacław Teliga – Management Board Member

Manner of representation

Each member of the management board is authorised to make declarations of will on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Jan Święszkowskiage 71	50	$675.31	50%
Karol Wacław Teligaage 80	50	$675.31	50%

Beneficial owners

No beneficial owners recorded for the company PPB 21.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Read-GeneS.A.	$2,163,474.84	read-gene.com
Vitrotest Europesp. z o.o.	$233,350.77	vitrotest.pl
VASA Therapeuticssp. z o.o.	$216,535.01	vasatherapeutics.com
MultiqureS.A.	$149,394.35	purebiologics.com
AI Corelabsp. z o.o.	$128,365.55	aicorelab.com
Pominnosp. z o.o.	$65,991.17	pominno.pl
GenomtecS.A.	$54,746.36	genomtec.com
4cell TherapiesS.A.	$9,123.06	4celltherapies.com
Centrum Transferu Technologii Meditransfer Iitdsp. z o.o.	$228.56	iitd.pan.wroc.pl
Olenasp. z o.o.	–	imsolutions.pl

FAQ

Last updated: 2026-10-07